GI Effects® Comprehensive Profile - Stool

GI Effects® Stool Profile

The GI Effects Comprehensive Stool Profile is the stool test of choice for optimizing clinical value in managing gut health and has been enhanced to now offer:

  • Further insight into gut flora by identifying 24 Commensal Bacteria targets using PCR technology
  • Identification of parasites using O&P technology
  • Biomarkers indicating levels of digestive and absorptive functions, as well as potential issues with gut inflammation and immunology

Why use targeted stool testing?
Gastrointestinal function is critical for good health. The intestinal tract contains significant amounts of bacteria which, when imbalanced, scientific literature has associated with a wide variety of common illnesses including, but not limited to:

  • Irritable Bowel Syndrome (IBS)
  • Inflammatory Bowel Disease (IBD)
  • Autoimmune Disorders
  • Diabetes
  • Cardiovascular Disease

Additionally, balancing gut microbiota is key for improving core gastrointestinal functions, such as digestion and absorption of nutrients, as well as metabolic functions. Poor digestion and malabsorption may impact immune function, optimum nutritional status, and mood.

Why is the GI Effects Comprehensive Stool Profile the best stool test for gastrointestinal diagnostics?
By evaluating targeted biomarkers, the GI Effects Comprehensive Stool Profile can reveal hidden conditions that other stool tests may overlook. Now with the use of Calprotectin, the GI Effects Comprehensive Stool Profile is a simple, yet more superior stool test that has the ability to differentiate Irritable Bowel Syndrome from Inflammatory Bowel Disease. Other benefits include:

  • More Actionable Results
    GI Effects Stool Profiles utilize the best technologies available to manage gut health, including enhanced molecular (PCR) technical performance, an expanded number of commensal targets, detection of parasites, and premier inflammatory and metabolic biomarkers – all designed to increase the prevalence of clinically actionable results.
  • Enhanced Clinical Utility
    Our value-added report provides Interpretation At-a-Glance that provides immediate treatment insight via key biomarkers for Infection, Inflammation, Insufficiency, and Imbalances by using graphics designed to place immediate focus on the big picture. The Interpretation At-a-Glance also summarizes commensal bacterial patterns into global markers of gut health in a Diversity Association graphic. As well, our Relative Abundance graphic provides a comparison of the patient's microbial abundance to a healthy cohort of patients.
  • Option of 1-Day or 3-Day Specimen Collection
    Our GI Effects Stool Profiles allow the choice of either one- or three-day collection, based on your approach to diagnosis and the needs of your patient.
  • NEW Biomarkers & Add-ons
    The GI Effects Comprehensive Stool Profile now includes biomarkers such as Calprotectin and Pancreatic Elastase 1, as well as premier inflammatory and metabolic biomarkers such as EPX and Beta-glucaronidase. It also offers five additional add-ons – including EIA assessment of pathogenic bacteria – for greater utility: HpSA - H.pylori, Campylobacterspp, Clostridium difficile, Shiga toxin E. coli and Fecal Lactoferrin.

Test Type: Stool Test


  • Acetate
  • Acetate %
  • Achromobacter/Alcaligenes spp.
  • Aeromonas spp.
  • Ancylostoma-Necator Sp.
  • Ascaris lumbricoides
  • Bacillus spp.
  • Bacteroides spp.
  • Bacteroidetes
  • Balantidium Coli
  • Bifidobacter spp.
  • Blastocystis hominis
  • Butyrate %
  • Candida spp.
  • Charcot-leyden crystals
  • Chilomastix mesnilli
  • Cholesterol
  • Citrobacter spp.
  • Clonorchis sinensis
  • Clostridia spp.
  • Color
  • Cyclospora ceyatanensis
  • Dientamoeba fragilis
  • Diphyllobothrium latum
  • Echinococcus granulosus
  • Echinococcus multi-locularis
  • Elastase 1
  • Endolimax nana
  • Entamoeba coli
  • Entamoeba hartmani
  • Entamoeba histolytica/dispar
  • Enterobacter spp.
  • Enterobius vermicularis
  • Enteromonis hominis
  • Escherichia coli
  • Fasciola hepatica
  • Fasciolopsis buski
  • Fecal sIgA
  • Firmicutes
  • Fusobacteria spp.
  • Geotrichum spp.
  • Giardia lamblia
  • Hymenopelis diminuta
  • Hymenopolis nana
  • Iodamoeba beutschlii
  • Isospora belli
  • Klebsiella oxytoca
  • Klebsiella pneumoniae
  • LCFAs
  • Lactobacillus spp.
  • Lactoferrin
  • Metagonimus yokogawai
  • Morganella morganii
  • Mucus
  • Mycoplasma spp.
  • No ova or parasites seen
  • Paragonimus westermani
  • Prevotella spp.
  • Propionate
  • Propionate %
  • Pseudomonas spp.
  • Putrefactive SCFA
  • RBCs
  • Retortamonas hominis
  • Rhodotorula spp.
  • Saccharomyces spp.
  • Salmonella spp.
  • Schistosoma haematobium
  • Schistosoma japonicum
  • Schistosoma mansoni
  • Schistosoma mekongi
  • Staphylococcus aureus
  • Streptomyces spp.
  • Strongyloides stercoralis
  • Taenia sp.
  • Taxonomy Unknown
  • Total Fat
  • Total SCFA
  • Toxocara sp.
  • Trichomonas hominis
  • Trichuris trichiura
  • Triglycerides
  • Valerate %
  • Vegetable Fibers
  • Vibrio spp.
  • WBCs
  • Yersinia spp.
  • i-Butyrate
  • i-Valerate
  • n-Butyrate
  • n-Valerate
  • pH

Turn Around Time: 

17 Days

© 1998 - 2014 Genova Diagnostics (GDX)
This website is intended for educational purposes only. It is not meant for use as diagnostic information and is part of Genova Diagnostics' communication with physicians and patients.